YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Cadila Health
Cadila Health
BSE: 532321NSE: CADILAHCISIN: INE010B01027

20th-Oct-2020 10:24Source: NSE

Cadila Healthcare Limited

Cadila Healthcare Limited has informed the Exchange regarding a press release dated October 20, 2020, titled "Zydus Cadila receives Final Approval from USFDA for Solifenacin Succinate Tablets".

Sections